In breast cancer, such events commonly affect receptor tyrosine kinases, PTEN, PIK3CA and, to a lesser degree, AKT1. PIK3CA as well as AKT1 mutations have been described as early events in the breast cancer development process [3-6]. Here, NTRK1 is linked to breast cancer.